Options for low-risk prostate cancer – 1
Narrator: This is NIH Health Matters. I’m Joe Balintfy. An independent panel at the NIH has concluded that patients with low-risk prostate cancer should be offered the option of active surveillance.
Ganz: We feel confident that in the very low-risk patients that this is a reasonable thing to offer men when they are being told that they have this diagnosis.
Narrator: Panel chairperson Dr. Patricia Ganz is from UCLA. She explains that more men are being diagnosed with very low-risk, slow-growing prostate cancer and may not choose surgery or radiation immediately, but want to be followed.
Ganz: And if at some time their disease pattern changes, they would like to then go ahead with active treatment at that time.
Narrator: For details, visit the website consensus.nih.gov. Health Matters is produced by the NIH, part of the U.S. Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.